Health
COVID-19: Cambridge vaccine gets £1.9 million to begin clinical trials – BBC Focus Magazine
Scientists at Cambridge say they aim to make a vaccine that will not only protect from SARS-CoV-2, but also other related coronaviruses.
A coronavirus vaccine candidate developed by the University of Cambridge could begin clinical trials in the UK in the autumn.
A £1.9 million funding boost from Innovate UK, the governments innovation agency, has provided support for a collaboration between Cambridge spin-out company DIOSynVax, the University of Cambridge and the University Hospital Southampton NHS Foundation Trust.
The funding of £1.9 million will allow the team to take the vaccine candidate to clinical trial at the University…
-
General14 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General15 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News24 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General14 hours agoOf saints and sinners | The Spectator Australia